Euphorbia royleana
Euphorbia royleana · Accepted scientific name
Scientific literature: Very Sparse (4 studies) · ★☆☆☆☆
Euphorbia royleana is a plant species that holds significant pharmacological potential due to its diverse biological activities. Research indicates that various preparations, including aqueous, ethanol, and hexane extracts, as well as the plant's latex, exhibit potent antimicrobial, antioxidant, antitumor, and cytotoxic properties. The stem is a primary source for these bioactive components, which are notably rich in flavonoids. These chemical constituents have demonstrated effectiveness in combating oxidative stress and inhibiting the growth of pathogens such as Aspergillus niger, Bacillus pumilus, and E. coli. Consequently, this species serves as a valuable subject for studying natural compounds with wide-ranging therapeutic applications.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Euphorbiaceae
- Distribution
- Africa
- Plant Parts
- Stem
Classification
Common Names
Euphorbia royleana is a unique botanical species known by several different names across various regions. It is frequently referred to by its common English name, the Royle piimalill. In other parts of the world, this plant is widely recognized as the Sullu Spurge. Those searching for its identity in Cyrillic scripts will find it listed as Молочай Ройля. Regardless of the terminology used, this plant remains a distinct member of its genus.
Sources: Catalogue of Life (COL)
Taxonomy
Euphorbia royleana is a distinct member of the kingdom Plantae. This plant is classified under the class Equisetopsida and belongs to the order Malpighiales. Within this taxonomic framework, it is a specific representative of the genus Euphorbia. Furthermore, it falls under the family Euphorbiaceae, which defines its botanical connections. Understanding these relationships provides essential insight into the biological identity of this species.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Euphorbiaceae |
| Genus | Euphorbia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Euphorbia royleana is a versatile plant species with a broad geographical presence across various Asian regions. Its distribution spans the temperate zones of China, including both the South-Central and Southeast territories. The plant is also commonly found throughout Eastern Asia, specifically within the island of Taiwan. Moving into tropical climates, it thrives across the Indian Subcontinent, notably in areas like Assam. Furthermore, its range extends into the unique landscapes of the East Himalaya, showcasing its ability to adapt to diverse environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Euphorbia royleana develops into a distinct shrubby growth form. This plant is naturally self-supporting, allowing it to maintain its structure without external assistance.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Euphorbia royleana has emerged as a significant medicinal plant with a diverse range of biological properties. Research indicates that the plant exhibits strong antioxidant activity, particularly through the scavenging of free radicals. Furthermore, its extracts demonstrate effective antimicrobial action against various bacteria and fungi. The study also highlights its potential antitumor capabilities, which are supported by notable cytotoxic effects observed in laboratory assays. Ultimately, these findings suggest that the plant holds great promise for the isolation of bioactive compounds within the pharmaceutical industry.
Compounds
Euphorbia royleana is a medicinal plant from Pakistan that shows significant promise for pharmaceutical applications. Scientific analysis of its extracts reveals a high concentration of bioactive compounds, most notably flavonoids. Specifically, the hexane extract of the plant was found to contain the highest flavonoid content, measured in quercetin equivalents. These chemical constituents contribute to the plant's impressive antioxidant, antimicrobial, and cytotoxic properties. Consequently, this species serves as a valuable natural source for isolating compounds used in medical treatments.
Conditions
Euphorbia royleana demonstrates significant antimicrobial properties by effectively treating the fungus Aspergillus niger and the bacteria Bacillus subtilis. The plant also exhibits potent antibacterial activity against Bacillus pumilus and Escherichia coli. In addition to these microbial interactions, its extracts are highly effective at treating oxidative stress by scavenging DPPH free radicals. These diverse biological activities highlight the plant's potential for pharmaceutical applications in combating both infection and oxidative damage.
Preparations
Euphorbia royleana is prepared as aqueous extracts, hexane extracts, and methanol extracts to evaluate various antioxidant and antimicrobial activities. The plant is also prepared as an ethanol extract, which has been used to derive benzoic acid derivatives from endophytic fungi. Additionally, Euphorbia royleana is prepared as latex to serve as a bio-reductant for the synthesis of silver nanoparticles. These preparations further include the use of latex extract to mediate nanoparticles that exhibit potent antibacterial and hepatoprotective properties. Through these diverse methods, the different forms of the plant demonstrate significant potential for pharmaceutical and nanotherapeutic applications.
Parts used
Euphorbia royleana serves as a significant botanical source for the isolation of diverse bioactive diterpenoids. Recent chemical investigations have focused specifically on the plant's stem to extract various ingenane, ent-atisane, and ent-kaurane-type compounds. Through the use of methanolic extraction and advanced spectroscopic methods, researchers have successfully identified several unique structures and their absolute configurations. These stem-derived compounds have demonstrated notable biological potential, particularly in their ability to inhibit nitric oxide in stimulated cells. Ultimately, molecular docking studies continue to provide deeper insights into the therapeutic mechanisms offered by these specific plant components.